Vabysmo 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection Images
Generic Name: faricimab
This medication has been identified as Vabysmo 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection. It is supplied by Genentech, Inc.
Vabysmo is used in the treatment of Macular Edema Following Retinal Vein Occlusion; Macular Edema; Macular Degeneration; Diabetic Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Vabysmo 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Vabysmo
- Generic Name
- faricimab
- Strength
- 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0096
See also:
More about Vabysmo (faricimab ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (36)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.